Melanoma sentinel node biopsy and prediction models for relapse and overall survival-Reference-Cited by-同舟云学术

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

Published:2010-09-21 Issue:8 Volume:103 Page:1229-1236
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Mitra A,Conway C,Walker C,Cook M,Powell B,Lobo S,Chan M,Kissin M,Layer G,Smallwood J,Ottensmeier C,Stanley P,Peach H,Chong H,Elliott F,Iles M M,Nsengimana J,Barrett J H,Bishop D T,Newton-Bishop J A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605849.pdf

Reference43 articles.

1. Balch CM, Sober AJ, Soong SJ, Gershenwald JE (2003) The new melanoma staging system. Semin Cutan Med Surg 22: 42–54

2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A (2001) Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622–3634

3. Clark Jr WH, Elder DE, Guerry Dt, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC (1989) Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81: 1893–1904

4. Cochran AJ, Elashoff D, Morton DL, Elashoff R (2000) Individualized prognosis for melanoma patients. Hum Pathol 31: 327–331

5. Conway C, Mitra A, Jewell R, Randerson-Moor J, Lobo S, Nsengimana J, Edward S, Sanders DS, Cook M, Powell B, Boon A, Elliott F, de Kort F, Knowles MA, Bishop DT, Newton-Bishop J (2009) Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res 15: 6939–6946

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy;European Journal of Cancer;2024-05

2. Sentinel lymph node assessment in melanoma: current state and future directions;Histopathology;2023-08

3. Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?;Annals of Surgical Oncology;2022-10-06

4. Predictive Values of Pathological and Clinical Risk Factors for Positivity of Sentinel Lymph Node Biopsy in Thin Melanoma: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-01-27

5. MelRisk: Using neutrophil-to-lymphocyte ratio to improve risk prediction models for metastatic cutaneous melanoma in the sentinel lymph node;Journal of Plastic, Reconstructive & Aesthetic Surgery;2021-12